Knight Capital Group’s TRIUS THERAPEUTICS INC COM STK (DE) TSRX Stock Holding History

Knight Capital Group’s Portfolio TSRX Stock Details TSRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$343K	Buy	+42,282	New	+$312K	0.01%	2092

Other funds holding TSRX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCM

Harvey Capital Management Palm Beach, Florida $439M AUM 37.68% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Knight Capital Group's TSRX Position: Q2 2013 in Review

Knight Capital Group opened a new position in TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) in Q2 2013: 42,282 shares worth $343K. The stake represents 0.01% of the portfolio and ranks #2092 among its holdings.

84 funds tracked by Wall St. Rank hold TSRX as of Q2 2013.

Knight Capital Group held 42,282 shares of TRIUS THERAPEUTICS INC COM STK (DE) worth $343K as of Q2 2013.
TRIUS THERAPEUTICS INC COM STK (DE) was a new Knight Capital Group position in Q2 2013.
TRIUS THERAPEUTICS INC COM STK (DE) made up 0.01% of Knight Capital Group's portfolio in Q2 2013, its #2092 holding.
84 funds tracked by Wall St. Rank held TRIUS THERAPEUTICS INC COM STK (DE) as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.